Amphotericin B (Cystetic medicines)

两性霉素B (Cystetic medicines)

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAmphotericin B (Cystetic medicines)
Drug Alias NameABCI (Cystetic Medicines)Amphotericin B inhalation (Cystetic medicines)CM-001CM001
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionErgosterol bindersCell membrane permeability enhancers
TargetsErgosterol
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of IllinoisUniversity of Iowa Research Foundation
China Registration ClassN/A

Develop Information

Active CompaniesCystetic Medicines Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A